Private equity company Permira is looking to offload its CDMO Cambrex in a sale that could value the latter company at up to $4 billion, according to a report over the weekend by the Financial Times.

Societal CDMO manufactures drugs and medicines for other companies. SCTL is concentrating on expanding its service offerings and finding clients in the early stages of treatment development to offset ...

Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to ...

The pharmaceutical industry has undergone significant evolution within the past few decades, most notably within the past 10-15 years. Specifically, recently extremely relevant biopharmaceutical ...

NightHawk Biosciences, a biotech that was developing medical countermeasures to defend against emerging biothreats, is officially dropping R&D and sending associated staff out the door to fully focus ...

@2024 - All Right Reserved.

Charles River Laboratories International, Inc. CRL recently announced a viral vector contract development and manufacturing organization (CDMO) partnership with Rznomics Inc. South Korea-based ...

The global radiopharmaceutical CDMO market is anticipated to grow at an estimated rate of around 9% over the next five years. This expansion is driven by the high costs and significant infrastructure ...

Altitude Marketing released its 2026 CDMO Marketing Trends Report, a quantitative analysis of marketing practices and organizational dynamics across the U.S. contract development and manufacturing ...